Because he gets both the USA trial and the EU tria
Post# of 72440
(Total Views: 342)
Posted On: 03/28/2019 12:04:42 PM
Because he gets both the USA trial and the EU trial for the price of one.
By having the P3 protocol include both the FDA and EMA requirements the single trial will satisfy both governmental bodies for their respective P3 trial. If they say there must be 300 patients in the trial, IPIX only needs to get 300 total patients between the US and EU trials to satisfy both since patients in either trial will meet the requirements of the other. Also makes it a heck of a lot easier to get all the patients at once since they can draw on a massive base of potential patients in both USA and EU. Whichever side costs less per patient, slew the major number of patients to that trial to save money. Also much lower Brilacidin has to be made up for only one total trial population whereas without satisfying both agencies they would have to test twice as many patients and have Brilacidin for all.
Very time efficient and financially a steal.
By having the P3 protocol include both the FDA and EMA requirements the single trial will satisfy both governmental bodies for their respective P3 trial. If they say there must be 300 patients in the trial, IPIX only needs to get 300 total patients between the US and EU trials to satisfy both since patients in either trial will meet the requirements of the other. Also makes it a heck of a lot easier to get all the patients at once since they can draw on a massive base of potential patients in both USA and EU. Whichever side costs less per patient, slew the major number of patients to that trial to save money. Also much lower Brilacidin has to be made up for only one total trial population whereas without satisfying both agencies they would have to test twice as many patients and have Brilacidin for all.
Very time efficient and financially a steal.
(5)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼